6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Behavioral Inhibition Deficits in Addiction
Behavioral inhibition refers to the brain’s ability to suppress impulsive actions or responses, a function that plays a crucial role in decision-making and self-control. In individuals with addiction, there is often a notable impairment in behavioral inhibition, which can lead to difficulty resisting urges to use substances even when aware of the negative consequences. These deficits are primarily linked to dysfunction in the prefrontal cortex, which regulates cognitive processes such as judgment and impulse control. Over time, chronic substance use can exacerbate these impairments, reinforcing the cycle of addiction. Interventions targeting behavioral inhibition, including cognitive-behavioral therapy (CBT) and other therapeutic techniques, are vital in helping individuals regain self-control, improve decision-making, and reduce the likelihood of relapse.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States